These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
295 related articles for article (PubMed ID: 30039732)
41. Comparison of Treatment Outcomes after Collagenase Injection and Percutaneous Needle Fasciotomy for Dupuytren's Contracture: Objective and Subjective Comparisons with a 3-Year Follow-Up. Abe Y Plast Reconstr Surg; 2020 Jun; 145(6):1464-1474. PubMed ID: 32459776 [TBL] [Abstract][Full Text] [Related]
42. Long-term recurrence of Dupuytren's disease treated with clostridium histolitycum collagenase. Surgical treatment and anatomopathological study. Simón-Pérez C; Rodríguez-Mateos JI; Maestro IA; Alvarez-Quiñones M; Simon-Perez E; Martín-Ferrero MA Arch Orthop Trauma Surg; 2024 May; 144(5):2085-2091. PubMed ID: 38653835 [TBL] [Abstract][Full Text] [Related]
44. A comparison of percutaneous needle fasciotomy and collagenase injection for dupuytren disease. Nydick JA; Olliff BW; Garcia MJ; Hess AV; Stone JD J Hand Surg Am; 2013 Dec; 38(12):2377-80. PubMed ID: 24060510 [TBL] [Abstract][Full Text] [Related]
45. Efficacy and safety of collagenase clostridium histolyticum for Dupuytren disease nodules: a randomized controlled trial. Costas B; Coleman S; Kaufman G; James R; Cohen B; Gaston RG BMC Musculoskelet Disord; 2017 Aug; 18(1):374. PubMed ID: 28854973 [TBL] [Abstract][Full Text] [Related]
46. Short-term efficacy and adverse effects of collagenase clostridium histolyticum injections, percutaneous needle fasciotomy and limited fasciectomy in the treatment of Dupuytren's contracture: a network meta-analysis of randomized controlled trials. Obed D; Salim M; Schlottmann F; Bingoel AS; Panayi AC; Dastagir K; Vogt PM; Koenneker S BMC Musculoskelet Disord; 2022 Oct; 23(1):939. PubMed ID: 36307837 [TBL] [Abstract][Full Text] [Related]
47. Collagenase treatment of Dupuytren's contracture using a modified injection method: a prospective cohort study of skin tears in 164 hands, including short-term outcome. Atroshi I; Nordenskjöld J; Lauritzson A; Ahlgren E; Waldau J; Waldén M Acta Orthop; 2015 Jun; 86(3):310-5. PubMed ID: 25695745 [TBL] [Abstract][Full Text] [Related]
48. Three-Year Recurrence of Dupuytren Contracture after Needle Fasciotomy or Collagenase Injection: A Randomized Controlled Trial. Jørgensen RW; Jensen CH; Jørring S Plast Reconstr Surg; 2023 Feb; 151(2):365-371. PubMed ID: 36342689 [TBL] [Abstract][Full Text] [Related]
49. Analysis of efficacy and safety of treatment with collagenase Clostridium histolyticum among subgroups of patients with Dupuytren contracture. Raven RB; Kushner H; Nguyen D; Naam N; Curtin C Ann Plast Surg; 2014 Sep; 73(3):286-90. PubMed ID: 23511746 [TBL] [Abstract][Full Text] [Related]
50. Finger Joint Contractures 5 Years After Treatment for Dupuytren Disease: A Comparative Cohort Study of Collagenase Injection Versus Surgical Fasciectomy. Eckerdal D; Lauritzson A; Nordenskjöld J; Åkesson A; Atroshi I J Hand Surg Am; 2022 Sep; 47(9):834-842. PubMed ID: 35868901 [TBL] [Abstract][Full Text] [Related]
51. The treatment of Dupuytren disease. Desai SS; Hentz VR J Hand Surg Am; 2011 May; 36(5):936-42. PubMed ID: 21527148 [TBL] [Abstract][Full Text] [Related]
52. Five-Year Results of a Randomized, Controlled Trial of Collagenase Treatment Compared With Needle Fasciotomy for Dupuytren Contracture. Byström M; Ibsen Sörensen A; Samuelsson K; Fridén JO; Strömberg J J Hand Surg Am; 2022 Mar; 47(3):211-217. PubMed ID: 35074248 [TBL] [Abstract][Full Text] [Related]
54. Outcomes of Management of Recurrent Dupuytren Contracture: A Systematic Review and Meta-analysis. Wong CR; Huynh MNQ; Fageeh R; McRae MC Hand (N Y); 2022 Nov; 17(6):1104-1113. PubMed ID: 33618538 [TBL] [Abstract][Full Text] [Related]
55. [Collagenase Clostridum histolyticum in the management of Dupuytren's contracture]. Holzer LA; Holzer G Handchir Mikrochir Plast Chir; 2011 Oct; 43(5):269-74. PubMed ID: 21935843 [TBL] [Abstract][Full Text] [Related]
56. Multiple concurrent collagenase clostridium histolyticum injections to Dupuytren's cords: an exploratory study. Coleman S; Gilpin D; Tursi J; Kaufman G; Jones N; Cohen B BMC Musculoskelet Disord; 2012 Apr; 13():61. PubMed ID: 22540636 [TBL] [Abstract][Full Text] [Related]
57. Outcomes and Early Recurrence Following Enzymatic (Collagenase) Treatment of Moderate and Severe Dupuytren Contractures. David M; Smith G; Pinder R; Craigen M; Waldram M; Mishra A; Dickson D; Wu F; Brewster M J Hand Surg Am; 2020 Dec; 45(12):1187.e1-1187.e11. PubMed ID: 32861504 [TBL] [Abstract][Full Text] [Related]
58. Clostridium histolyticum as first-line treatment of Dupuytren's disease. Hartig-Andreasen C; Schroll L; Lange J Dan Med J; 2019 Feb; 66(2):. PubMed ID: 30722822 [TBL] [Abstract][Full Text] [Related]
59. A single injection of collagenase clostridium histolyticum for the treatment of moderate Dupuytren's contracture: a 2 year follow-up of 47 patients. McFarlane J; Syed AM; Sibly TF J Hand Surg Eur Vol; 2016 Jul; 41(6):664-5. PubMed ID: 26269508 [No Abstract] [Full Text] [Related]
60. Collagenase Treatment for Dupuytren Disease of the Thumb and First Web. Dreise MM; Stenekes MW; Werker PM J Hand Surg Am; 2016 Mar; 41(3):348-53.e1. PubMed ID: 26803569 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]